A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.

Conclusions: Intravenous rt-PA was associated with lower patients' disabilities, fewer in-hospital days, and comparable total costs compared to conservative therapy for the management of AIS. PMID: 25297471 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25297471?dopt=Abstract

Source: Neurological Research - December 2, 2014 Category: Neurology Tags: Neurol Res Source Type: research